Approvable designations; Nonapprovable designation; Fast-track designation; Priority review; Orphan drug designations
Approvable designations
Nonapprovable designation
Fast-track designation
Orphan drug designations
Novo Nordisk Terminates Collaboration with Hims & Hers
June 23rd 2025The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide products. Novo Nordisk said that Hims & Hers continues to offer these compounded drugs.
Read More